484 related articles for article (PubMed ID: 23580243)
21. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
[TBL] [Abstract][Full Text] [Related]
22. Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome.
Ng SC; Lam EF; Lam TT; Chan Y; Law W; Tse PC; Kamm MA; Sung JJ; Chan FK; Wu JC
J Gastroenterol Hepatol; 2013 Oct; 28(10):1624-31. PubMed ID: 23800182
[TBL] [Abstract][Full Text] [Related]
23. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
[TBL] [Abstract][Full Text] [Related]
24. Is irritable bowel syndrome an infectious disease?
Thompson JR
World J Gastroenterol; 2016 Jan; 22(4):1331-4. PubMed ID: 26819502
[TBL] [Abstract][Full Text] [Related]
25. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
[TBL] [Abstract][Full Text] [Related]
26. Fecal microbiota transplantation for managing irritable bowel syndrome.
El-Salhy M; Mazzawi T
Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):439-445. PubMed ID: 29493330
[TBL] [Abstract][Full Text] [Related]
27. An Open-Labeled Study on Fecal Microbiota Transfer in Irritable Bowel Syndrome Patients Reveals Improvement in Abdominal Pain Associated with the Relative Abundance of Akkermansia Muciniphila.
Cruz-Aguliar RM; Wantia N; Clavel T; Vehreschild MJGT; Buch T; Bajbouj M; Haller D; Busch D; Schmid RM; Stein-Thoeringer CK
Digestion; 2019; 100(2):127-138. PubMed ID: 30423561
[TBL] [Abstract][Full Text] [Related]
28. Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress.
Sundin J; Rangel I; Fuentes S; Heikamp-de Jong I; Hultgren-Hörnquist E; de Vos WM; Brummer RJ
Aliment Pharmacol Ther; 2015 Feb; 41(4):342-51. PubMed ID: 25521822
[TBL] [Abstract][Full Text] [Related]
29. The Intestinal Microbiota and Irritable Bowel Syndrome.
Ringel Y; Ringel-Kulka T
J Clin Gastroenterol; 2015; 49 Suppl 1():S56-9. PubMed ID: 26447966
[TBL] [Abstract][Full Text] [Related]
30. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota.
Crouzet L; Gaultier E; Del'Homme C; Cartier C; Delmas E; Dapoigny M; Fioramonti J; Bernalier-Donadille A
Neurogastroenterol Motil; 2013 Apr; 25(4):e272-82. PubMed ID: 23433203
[TBL] [Abstract][Full Text] [Related]
31. Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options.
Bonfrate L; Tack J; Grattagliano I; Cuomo R; Portincasa P
Scand J Gastroenterol; 2013 Sep; 48(9):995-1009. PubMed ID: 23964766
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
Harris LA; Baffy N
Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
[TBL] [Abstract][Full Text] [Related]
33. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets.
Dupont HL
Aliment Pharmacol Ther; 2014 May; 39(10):1033-42. PubMed ID: 24665829
[TBL] [Abstract][Full Text] [Related]
34. Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome.
Ringel Y; Maharshak N
Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(8):G529-41. PubMed ID: 23886861
[TBL] [Abstract][Full Text] [Related]
35. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?
Bixquert Jiménez M
Rev Esp Enferm Dig; 2009 Aug; 101(8):553-64. PubMed ID: 19785495
[TBL] [Abstract][Full Text] [Related]
36. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM
Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
[TBL] [Abstract][Full Text] [Related]
37. Fecal microbiota transplantation in patients with irritable bowel syndrome: an overview of current studies.
Körner E; Lorentz A
J Appl Microbiol; 2023 Mar; 134(3):. PubMed ID: 36882216
[TBL] [Abstract][Full Text] [Related]
38. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice.
De Palma G; Lynch MD; Lu J; Dang VT; Deng Y; Jury J; Umeh G; Miranda PM; Pigrau Pastor M; Sidani S; Pinto-Sanchez MI; Philip V; McLean PG; Hagelsieb MG; Surette MG; Bergonzelli GE; Verdu EF; Britz-McKibbin P; Neufeld JD; Collins SM; Bercik P
Sci Transl Med; 2017 Mar; 9(379):. PubMed ID: 28251905
[TBL] [Abstract][Full Text] [Related]
39. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome.
Ringel Y; Ringel-Kulka T
J Clin Gastroenterol; 2011 Nov; 45 Suppl():S145-8. PubMed ID: 21992954
[TBL] [Abstract][Full Text] [Related]
40. Microbial signatures in post-infectious irritable bowel syndrome--toward patient stratification for improved diagnostics and treatment.
Jalanka J; Salonen A; Fuentes S; de Vos WM
Gut Microbes; 2015; 6(6):364-9. PubMed ID: 26512631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]